ABCL
$7.31
Abcellera Biologics
$.40
5.79%
ABCL
Earnings Whisper ®
N/A
2nd Quarter June 2023
Consensus:  ($0.13)
Revenue:  $12.58 Mil
Thursday
Aug 3
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Thursday, May 4, 2023

What do you expect when ABCL reports earnings?
Beat
Meet
Miss

Where is ABCL's stock price going from here?
Up
Flat
Down
Stock chart of ABCL
Analysts
Summary of analysts' recommendations for ABCL
Score
Grade
Pivots
Resistance
$7.95
$7.68
$7.49

$7.22

Support
$7.03
$6.76
$6.57
Tweet
Growth
Description
AbCellera Biologics Inc. is a technology company which searches, decodes and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera Biologics Inc. is based in Vancouver, Canada.
›